Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Long-term continuous terlipressin infusion in cirrhotic patients with hepatorenal syndrome or refractory ascites awaiting liver transplantation is associated with an increase in plasma sodium.

Literature DB >> 31700640

Long-term continuous terlipressin infusion in cirrhotic patients with hepatorenal syndrome or refractory ascites awaiting liver transplantation is associated with an increase in plasma sodium.

T McClure^1,2, B Chapman^1,2, P Hey^1,2, A Testro^1,2, P Gow^1,2.

Abstract

Entities: Chemical

Year: 2019 PMID： 31700640 PMCID： PMC6826519 DOI： 10.1177/2050640619878996

Source DB: PubMed Journal: United European Gastroenterol J ISSN： 2050-6406 Impact factor: 4.623

Keyword Cloud
References

× No keyword cloud information.

7 in total

1. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.

Authors: Paolo Angeli; Pere Ginès; Florence Wong; Mauro Bernardi; Thomas D Boyer; Alexander Gerbes; Richard Moreau; Rajiv Jalan; Shiv K Sarin; Salvatore Piano; Kevin Moore; Samuel S Lee; Francois Durand; Francesco Salerno; Paolo Caraceni; W Ray Kim; Vicente Arroyo; Guadalupe Garcia-Tsao
Journal: J Hepatol Date: 2015-01-28 Impact factor: 25.083

Review 2. Terlipressin: Current and emerging indications in chronic liver disease.

Authors: Timothy Papaluca; Paul Gow
Journal: J Gastroenterol Hepatol Date: 2018-03 Impact factor: 4.029

3. Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study.

Authors: Marta Cavallin; Salvatore Piano; Antonietta Romano; Silvano Fasolato; Anna Chiara Frigo; Gianpiero Benetti; Elisabetta Gola; Filippo Morando; Marialuisa Stanco; Silvia Rosi; Antonietta Sticca; Umberto Cillo; Paolo Angeli
Journal: Hepatology Date: 2016-02-03 Impact factor: 17.425

Long-term continuous terlipressin infusion in cirrhotic patients with hepatorenal syndrome or refractory ascites awaiting liver transplantation is associated with an increase in plasma sodium.

1. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites.

Review 2. Terlipressin: Current and emerging indications in chronic liver disease.

3. Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study.

4. Terlipressin therapy for moderate-to-severe hyponatraemia in patients with liver failure.

5. Effects of terlipressin on the aquaretic system: evidence of antidiuretic effects.

Review 6. Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.

7. Terlipressin for variceal bleeding induces large plasma sodium fluctuations in patients without cirrhosis.